Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Benign Neoplasm”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Not applicableLooking for participantsNCT06076538
What this trial is testing

PET/MR for Characterization of Renal Masses (RMs)

Who this might be right for
Renal TumorRenal Cell CarcinomaRenal Tumor, Benign
University of Texas Southwestern Medical Center 97
Large-scale testing (Phase 3)Looking for participantsNCT06349668
What this trial is testing

Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery

Who this might be right for
Other Specified Disorders of Kidney and UreterBenign Neoplasm of UreterCalculus of Kidney and Ureter+5 more
Hans Bahlmann 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT04258462
What this trial is testing

Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors

Who this might be right for
Benign Kidney NeoplasmKidney NeoplasmRenal Cell Cancer
Zhen Wang, MD 54
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableLooking for participantsNCT07395037
What this trial is testing

Ward Admissions for Haematuria

Who this might be right for
Urologic DiseasesHematuriaHematuria; Benign+3 more
British Urology Researchers in Surgical Training 1,050
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableStudy completedNCT05432232
What this trial is testing

The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy

Who this might be right for
Renal CancerTumor, SolidKidney Cancer+3 more
HistoSonics, Inc. 20
Not applicableActive Not RecruitingNCT05820087
What this trial is testing

The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

Who this might be right for
Renal CancerTumor, SolidKidney Cancer+2 more
HistoSonics, Inc. 67
Not applicableUnknownNCT03552497
What this trial is testing

The Potential of Radiomics to Differentiate Between Malignant and Benign Bosniak 3 Renal Cysts.

Who this might be right for
Renal Cyst Complex
Maastricht University 500
Not applicableStudy completedNCT07004426
What this trial is testing

Symptomatic and Incidental RCC Detection

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Benign Renal NeoplasmRenal Carcinoma
Charles University, Czech Republic 1,000
Not applicableWithdrawnNCT02061605
What this trial is testing

First-in-Human Safety Study Of Laser Tissue Welding For Surtureless Laparoscopic Partial Nephrectomy

Who this might be right for
Benign Renal TumorsMalignant Renal Tumors
Laser Tissue Welding, Inc.
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableLooking for participantsNCT06016075
What this trial is testing

Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques

Who this might be right for
Kidney Cancer
University of Cambridge 30
Large-scale testing (Phase 3)Study completedNCT00002641
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 350
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Not applicableActive Not RecruitingNCT07060248
What this trial is testing

A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.

Who this might be right for
Renal Cell Carcinoma (RCC)
Second Xiangya Hospital of Central South University 700
Testing effectiveness (Phase 2)Study completedNCT00126672
What this trial is testing

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Who this might be right for
Nonmalignant NeoplasmTuberous SclerosisLymphangioleimyomatosis+1 more
Dana-Farber Cancer Institute 36
Not applicableLooking for participantsNCT05728957
What this trial is testing

Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors

Who this might be right for
Kidney TumorRenal Benign NeoplasmRenal Malignant Tumor
Loyola University 100
Not applicableActive Not RecruitingNCT04761107
What this trial is testing

Impact of COVID-19 on GU Disease

Who this might be right for
COVID-19 InfectionGenitourinary CancerBenign Urologic Conditions
Icahn School of Medicine at Mount Sinai 15,240
Not applicableUnknownNCT03630926
What this trial is testing

Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.

Who this might be right for
Prostate CancerBenign Prostatic HypertrophyBladder Stones+1 more
Intermountain Health Care, Inc. 45